Zhongguo Zhou

13PUBLICATIONS
27CO-AUTHORS
Predictive and prognostic markersCancer therapy (excl. chemotherapy and radiation therapy)Tumour immunologyMedical biotechnology diagnostics (incl. biosensors)Radiation therapy
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (13)

|Apr 15, 2025
The Value of no Evidence of Disease (NED) in Intermediate-Stage Hepatocellular Carcinoma After TACE: A Real-World Study.

Lujun Shen, Yiquan Jiang, Yueqian Wu

|Feb 04, 2025
Transarterial Chemoembolization with Radiofrequency Ablation versus Surgical Resection for Small Late-Recurrence Hepatocellular Carcinoma.

Yao-Jun Zhang, Jinbin Chen, Zhongguo Zhou

|Jan 08, 2023
A Nomogram Based on Preoperative Lab Tests, BMI, ICG-R15, and EHBF for the Prediction of Post-Hepatectomy Liver Failure in Patients with Hepatocellular Carcinoma.

Deyao Zhang, Yangxun Pan, Zhenyun Yang

|Dec 23, 2022
Liver Tumor Markers, HALP Score, and NLR: Simple, Cost-Effective, Easily Accessible Indexes for Predicting Prognosis in ICC Patients after Surgery.

Deyao Zhang, Huilan Zeng, Yangxun Pan

|Dec 21, 2022
A risk-based postresection follow-up strategy for hepatocellular carcinoma patients.

Yizhen Fu, Xia Li, Zhenyun Yang

|Jul 08, 2022
PIM2 Expression Induced by Proinflammatory Macrophages Suppresses Immunotherapy Efficacy in Hepatocellular Carcinoma.

Jun-Cheng Wang, Dong-Ping Chen, Shi-Xun Lu

Pageof 3

Frequent Collaborators

7 joint publications

Yaojun Zhang

6 joint publications

Jinbin Chen

4 joint publications

Li Xu

3 joint publications

Yizhen Fu